Daidzein improves muscle atrophy caused by lovastatin by regulating the AMPK/FOXO3a axis
2024

Daidzein Improves Muscle Atrophy Caused by Lovastatin

Sample size: 8 publication 10 minutes Evidence: high

Author Information

Author(s): Wang Keke, Zeng Hao, Yang Hua

Primary Institution: State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University

Hypothesis

Can daidzein improve lovastatin-induced muscle atrophy and what is the specific mechanism?

Conclusion

Daidzein effectively alleviates lovastatin-induced skeletal muscle atrophy by inhibiting the AMPK/FOXO3a pathway.

Supporting Evidence

  • Daidzein reduced serum creatine kinase levels in mice.
  • Daidzein improved muscle grip strength in mice.
  • Daidzein inhibited the phosphorylation of FOXO3a induced by lovastatin.
  • Daidzein reversed the upregulation of muscle degradation proteins Atrogin-1 and MuRF-1.

Takeaway

Daidzein is a natural compound that helps muscles stay strong even when taking a medicine called lovastatin, which can make muscles weak.

Methodology

The study used mice and zebrafish models to test the effects of daidzein on muscle atrophy induced by lovastatin, measuring muscle strength and protein levels.

Limitations

The study primarily focused on animal models, and further research is needed to confirm the effects in humans.

Participant Demographics

Male C57BL/6J mice aged 6-8 weeks were used in the study.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/s13020-024-01034-5

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication